Cataract Clinical Trial
Official title:
Visual Field Changes in Patients Undergoing TECNIS ZCB00 Monofocal vs. TECNIS Symfony Extended Depth of Focus Intraocular Lens Implantation
Glaucoma is a leading cause of blindness worldwide. Damage to the optic nerve results in vision loss gradually. This vision loss can be detected by using visual field testing, and is a way of monitoring glaucoma progression. As this population ages, cataracts develop, and patients need to undergo cataract surgery to replace the cloudy crystalline lens with an artificial intraocular lens (IOL). The standard of treatment is implantation of a monofocal IOL, but this limits depth of focus and does not allow clear vision at both distance and near without glasses post-operatively. Multifocal and trifocal lenses split light into multiple distinct foci at near, intermediate and far distances without glasses correction. However, these lenses have been shown to reduce contrast sensitivity and impair visual field testing results, and are not recommended in patients with glaucoma. The TECNIS Symfony IOL has recently been approved by Health Canada and offers an extended range of vision with a single elongated focal point to allow patients to see at both distance and near. The lens is advertised to enhance contrast sensitivity, but it is currently unknown whether the TECNIS Symfony IOL impacts visual field testing. We will study the visual field changes in patients undergoing both TECNIS ZCB00 monofocal and TECNIS Symfony extended depth of focus IOL implantation during cataract surgery. The results of this study will impact the advice cataract surgeons give to patients with glaucoma, regarding whether this population of patients would benefit from a standard monofocal IOL implantation or an extended depth of focus TECNIS Symfony IOL implantation.
Primary open angle glaucoma is a leading cause of blindness worldwide, and is the most common
form of glaucoma. This condition involves progressive damage to the optic nerve over time and
ultimately vision loss that can be detected using standard automated perimetry visual field
testing. As this population ages, patients will eventually develop cataracts and require
cataract surgery to replace the cloudy crystalline lens with an artificial intraocular lens.
The standard of treatment is implantation of a monofocal intraocular lens (IOL), but this
limits depth of focus and does not allow clear vision at both distance and near without
spectacle correction post-operatively. To provide a refractive component to cataract surgery,
multifocal and trifocal lenses were introduced and split light into multiple distinct foci at
near, intermediate and far distances without correction. However, splitting of incoming light
has the potential to decrease contrast sensitivity and increase photic phenomena. In
addition, multifocal IOLs have been shown to reduce mean deviation on automated perimetry
compared to monofocal IOLs and are not recommended in patients where visual field reduction
may not be tolerated, such as in patients with glaucoma. The TECNIS Symfony IOL has been
recently been approved by Health Canada and offers extended range of vision with a single
elongated focal point, corrects for chromatic aberration and results in contrast enhancement.
It is unknown whether this new IOL impacts visual field testing in glaucoma patients post
cataract surgery.
The objective of this study is to compare visual field outcomes in patients choosing to
undergo cataract surgery with either a TECNIS ZCB00 monofocal vs TECNIS Symfony extended
depth of focus intraocular lens.
It is hypothesized that patients who undergo implantation of a TECNIS Symfony extended depth
of focus intraocular lens will have impaired visual field testing (a decrease in mean
deviation on Humphrey 24-2 standard automated perimetry) compared to those undergoing TECNIS
ZCB00 monofocal intraocular lens implantation.
This will be a prospective cohort study.
Patients undergoing either TECNIS ZCB00 monofocal or TECNIS Symfony extended depth of focus
ZXR intraocular lens insertion during cataract surgery will be recruited.
Patients will not be approached regarding the study until the patient decides which lens will
be inserted during surgery. This study has no impact on a patient's choice of intraocular
lens. This study will not be assigning a lens as part of the intervention.
There will be no randomization of the groups, given that patients will be choosing which lens
will be implanted during surgery pre-operatively, as any other patient undergoing cataract
surgery would.
There will be no blinding of study participants or of the investigators.
As per standard pre-operative assessment, patients will have ocular Biometry performed prior
to surgery to assess what prism diopter lens to insert intra-operatively.
On the day of this appointment, participants will be asked to perform a 24-2 Humphrey
standard automated perimetry visual field test with Swedish Interactive Threshold Algorithm
(SITA) standard thresholds.
In addition, at the 1-month post-operative appointment, participants will be asked to again
complete a 24-2 Humphrey visual field, in addition to the standard post-operative
examination.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |